Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Gayathri Anandhan, Yogesh B. Narkhede, Manikandan Mohan & Premasudha Paramasivam. (2023) Immunoinformatics aided approach for predicting potent cytotoxic T cell epitopes of respiratory syncytial virus. Journal of Biomolecular Structure and Dynamics 41:21, pages 12093-12105.
Read now
Read now
J.A Soto, N.M.S Galvez, D.B Rivera, F.E Díaz, C.A Riedel, S.M Bueno & A.M Kalergis. (2022) From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection. Expert Opinion on Drug Discovery 17:11, pages 1237-1259.
Read now
Read now
Rauf Bhat, Mohamed A. Farrag & Fahad N. Almajhdi. (2020) Double-edged role of natural killer cells during RSV infection. International Reviews of Immunology 39:5, pages 233-244.
Read now
Read now
William Flight & Andrew Jones. (2017) The diagnosis and management of respiratory viral infections in cystic fibrosis. Expert Review of Respiratory Medicine 11:3, pages 221-227.
Read now
Read now
Susanna Esposito, Elisa Scarselli, Mara Lelii, Alessia Scala, Alessandra Vitelli, Stefania Capone, Marco Fornili, Elia Biganzoli, Annalisa Orenti, Alfredo Nicosia, Riccardo Cortese & Nicola Principi. (2016) Antibody response to respiratory syncytial virus infection in children <18 months old. Human Vaccines & Immunotherapeutics 12:7, pages 1700-1706.
Read now
Read now
Charles J. Russell & Julia L. Hurwitz. (2016) Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses. Expert Review of Vaccines 15:2, pages 189-200.
Read now
Read now
Hongjing Gu, Tieling Li, Lina Han, Ping Zhu, Peirui Zhang, Shaogeng Zhang, Sujing Sun, Yueqiang Duan, Li Xing, Zhongpeng Zhao, Chengcai Lai, Bohai Wen, Xiliang Wang & PengHui Yang. (2015) Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination . Human Vaccines & Immunotherapeutics 11:4, pages 1057-1064.
Read now
Read now
Crystal Passmore, Paul E Makidon, Jessica J O’Konek, Joseph A Zahn, Jessie Pannu, Tarek Hamouda, Vira Bitko, Andrzej Myc, Nicolas W Lukacs, Ali Fattom & James R Baker Jr. (2014) Intranasal immunization with W805EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model. Human Vaccines & Immunotherapeutics 10:3, pages 615-622.
Read now
Read now
Kerry-Ann F O’Grady, Anne B Chang & Keith Grimwood. (2014) Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations. Expert Review of Respiratory Medicine 8:1, pages 43-55.
Read now
Read now
Patricia A Jorquera, Katie E Oakley & Ralph A Tripp. (2013) Advances in and the potential of vaccines for respiratory syncytial virus. Expert Review of Respiratory Medicine 7:4, pages 411-427.
Read now
Read now
Patricia Kaaijk, Willem Luytjes & Nynke Y. Rots. (2013) Vaccination against RSV. Human Vaccines & Immunotherapeutics 9:6, pages 1263-1267.
Read now
Read now
Articles from other publishers (67)
Alvaro Proaño & Dustin Daniel Flannery. (2023)
EBNEO
Commentary: Respiratory syncytial virus vaccine in pregnancy for infant protection
. Acta Paediatrica 112:11, pages 2449-2450.
Crossref
Crossref
Swechha M. Pokharel, Indira Mohanty, Charles Mariasoosai, Tanya A. Miura, Lisette A. Maddison, Senthil Natesan & Santanu Bose. (2023) Human beta defensin-3 mediated activation of β-catenin during human respiratory syncytial virus infection: interaction of HBD3 with LDL receptor-related protein 5. Frontiers in Microbiology 14.
Crossref
Crossref
Abu Tayab Moin, Md. Asad Ullah, Rajesh B. Patil, Nairita Ahsan Faruqui, Yusha Araf, Sowmen Das, Khaza Md. Kapil Uddin, Md. Shakhawat Hossain, Md. Faruque Miah, Mohammad Ali Moni, Dil Umme Salma Chowdhury & Saiful Islam. (2023) A computational approach to design a polyvalent vaccine against human respiratory syncytial virus. Scientific Reports 13:1.
Crossref
Crossref
Chandrav De, Raymond J. Pickles, Wenbo Yao, Baolin Liao, Allison Boone, Mingyu Choi, Diana M. Battaglia, Frederic B. Askin, Jason K. Whitmire, Guido Silvestri, J. Victor Garcia & Angela Wahl. (2023) Human T cells efficiently control RSV infection. JCI Insight 8:11.
Crossref
Crossref
Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, Tomer Zohar, Sivakumar Periasamy, Nickita Mehta, Jeroen Tolboom, Leslie Van der Fits, Jerry Sadoff, Christy Comeaux, Benoit Callendret, Alexander Bukreyev, Douglas A. Lauffenburger, Arangassery Rosemary Bastian & Galit Alter. (2022) Antibody effector functions are associated with protection from respiratory syncytial virus. Cell 185:26, pages 4873-4886.e10.
Crossref
Crossref
Rahul Ahuja, Asha Shelly, Jairam Meena & Amulya K. Panda. (2022) Microparticles entrapping pneumococcal protein SP0845 show improved immunogenicity and temperature stability. International Journal of Biological Macromolecules 203, pages 661-670.
Crossref
Crossref
Anna A. Shtro, Galina D. Petukhova & Aleksandra S. Romanova. (2022) Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State. Molecules 27:7, pages 2263.
Crossref
Crossref
Emanuele Andreano, Ida Paciello, Monia Bardelli, Simona Tavarini, Chiara Sammicheli, Elisabetta Frigimelica, Silvia Guidotti, Giulia Torricelli, Marco Biancucci, Ugo D’Oro, Sumana Chandramouli, Matthew J Bottomley, Rino Rappuoli, Oretta Finco & Francesca Buricchi. (2021) The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors. EMBO Molecular Medicine 13:6.
Crossref
Crossref
Fabián E. Díaz, Mariana Guerra-Maupome, Paiton O. McDonald, Daniela Rivera-Pérez, Alexis M. Kalergis & Jodi L. McGill. (2021) A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus. Frontiers in Immunology 12.
Crossref
Crossref
Abu Hamza, Zoya Shafat, Zahoor Ahmad Parray, Malik Hisamuddin, Wajihul Hasan Khan, Anwar Ahmed, Fahad N. Almajhdi, Mohamed A. Farrag, Arif Ahmed Mohammed, Asimul Islam & Shama Parveen. (2021) Structural Characterization and Binding Studies of the Ectodomain G Protein of Respiratory Syncytial Virus Reveal the Crucial Role of pH with Possible Implications in Host–Pathogen Interactions. ACS Omega 6:15, pages 10403-10414.
Crossref
Crossref
Jerald Sadoff, Els De Paepe, Wouter Haazen, Edmund Omoruyi, Arangassery R Bastian, Christy Comeaux, Esther Heijnen, Cynthia Strout, Hanneke Schuitemaker & Benoit Callendret. (2021) Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults. The Journal of Infectious Diseases 223:4, pages 699-708.
Crossref
Crossref
Roshan Goswami, Derek T. O’Hagan, Roberto Adamo & Barbara C. Baudner. (2021) Conjugation of Mannans to Enhance the Potency of Liposome Nanoparticles for the Delivery of RNA Vaccines. Pharmaceutics 13:2, pages 240.
Crossref
Crossref
Thomas J. Brouwers & Bernard A.M. Van der Zeijst. 2021. Encyclopedia of Virology. Encyclopedia of Virology
281
288
.
Salman Ahmad Mustfa, Eleonora Maurizi, John McGrath & Ciro Chiappini. (2020) Nanomedicine Approaches to Negotiate Local Biobarriers for Topical Drug Delivery. Advanced Therapeutics 4:1, pages 2000160.
Crossref
Crossref
Wayne Harshbarger, Sai Tian, Newton Wahome, Ankita Balsaraf, Deep Bhattacharya, Desheng Jiang, Ratnesh Pandey, Kunal Tungare, Kristian Friedrich, Nurjahan Mehzabeen, Marco Biancucci, Diana Chinchilla-Olszar, Corey P. Mallett, Ying Huang, Zihao Wang, Matthew James Bottomley, Enrico Malito & Sumana Chandramouli. (2020) Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F. PLOS Pathogens 16:11, pages e1008943.
Crossref
Crossref
MengJie Hu, Marie A. Bogoyevitch & David A. Jans. (2020) Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies. Physiological Reviews 100:4, pages 1527-1594.
Crossref
Crossref
Lori Bedient, Swechha Mainali Pokharel, Kim R. Chiok, Indira Mohanty, Sierra S. Beach, Tanya A. Miura & Santanu Bose. (2020) Lytic Cell Death Mechanisms in Human Respiratory Syncytial Virus-Infected Macrophages: Roles of Pyroptosis and Necroptosis. Viruses 12:9, pages 932.
Crossref
Crossref
Ismail Sebina & Simon Phipps. (2020) The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis. Viruses 12:8, pages 808.
Crossref
Crossref
Rhiannon R. PenkertJane S. HankinsNeal S. YoungJulia L. Hurwitz. (2020) Vaccine Design Informed by Virus-Induced Immunity. Viral Immunology 33:4, pages 342-350.
Crossref
Crossref
MengJie Hu, Marie A. Bogoyevitch & David A. Jans. (2019) Subversion of Host Cell Mitochondria by RSV to Favor Virus Production is Dependent on Inhibition of Mitochondrial Complex I and ROS Generation. Cells 8:11, pages 1417.
Crossref
Crossref
Kirsten Schneider-Ohrum, Angie Snell Bennett, Gaurav Manohar Rajani, Leigh Hostetler, Sean K. Maynard, Michelle Lazzaro, Lily I. Cheng, Terrence O’Day & Corinne Cayatte. (2019)
CD4
+
T Cells Drive Lung Disease Enhancement Induced by Immunization with Suboptimal Doses of Respiratory Syncytial Virus Fusion Protein in the Mouse Model
. Journal of Virology 93:15.
Crossref
Crossref
AKSHAY ASHOK .MANJUSHA GOEL .BHARTI CHAUBEY .RAJESH PATIL .. (2019) VITAMIN D LEVEL IN CRITICALLY ILL CHILDREN 6 MONTHS–5 YEARS AGE ADMITTED TO INTENSIVE CARE UNIT IN TERTIARY CARE HOSPITAL OF CENTRAL INDIA. Indian Journal of Child Health 06:04, pages 413-415.
Crossref
Crossref
MengJie MengJie Hu, Keith E Schulze, Reena Ghildyal, Darren C Henstridge, Jacek L Kolanowski, Elizabeth J New, Yuning Hong, Alan C Hsu, Philip M Hansbro, Peter AB Wark, Marie A Bogoyevitch & David Andrew Jans. (2019) Respiratory Syncytial Virus co-opts host mitochondrial function to favour infectious virus production. eLife 8.
Crossref
Crossref
Xueting Qiu, Venkata R. Duvvuri & Justin Bahl. (2019) Computational Approaches and Challenges to Developing Universal Influenza Vaccines. Vaccines 7:2, pages 45.
Crossref
Crossref
María José Altamirano-Lagos, Fabián E. Díaz, Miguel Andrés Mansilla, Daniela Rivera-Pérez, Daniel Soto, Jodi L. McGill, Abel E. Vasquez & Alexis M. Kalergis. (2019) Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus. Frontiers in Microbiology 10.
Crossref
Crossref
Mariana Guerra-Maupome, Mitchell V. Palmer, Jodi L. McGill & Randy E. Sacco. (2019) Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection. Vaccines 7:1, pages 7.
Crossref
Crossref
Inam Ullah Khan, Jiansheng Huang, Xue Li, Jun Xie & Naishuo Zhu. (2018) Nasal immunization with RSV F and G protein fragments conjugated to an M cell-targeting ligand induces an enhanced immune response and protection against RSV infection. Antiviral Research 159, pages 95-103.
Crossref
Crossref
Kedir N. Turi, Lindsey Romick-Rosendale, Tebeb Gebretsadik, Miki Watanabe, Steven Brunwasser, Larry J. Anderson, Martin L. Moore, Emma K. Larkin, Ray Stokes PeeblesJr.Jr. & Tina V. Hartert. (2018) Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing. Metabolomics 14:10.
Crossref
Crossref
Tiago Fazolo, Rodrigo Benedetti Gassen, Deise Nascimento de Freitas, Thiago J. Borges, Maurício Menegatti Rigo, Rodrigo Dornelles da Silva, Fábio Maito, Aline Cunha, Daniel Augusto Gasparin Bueno Mendes, André Báfica, José Eduardo Vargas, Ana Paula Duarte de Souza & Cristina Bonorino. (2018) Vaccination with RSV M 209-223 peptide promotes a protective immune response associated with reduced pulmonary inflammation. Antiviral Research 157, pages 102-110.
Crossref
Crossref
Aleisha J. Anderson, Tom L. Snelling, Hannah C. Moore & Christopher C. Blyth. (2017) Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children. Pediatric Drugs 19:6, pages 523-531.
Crossref
Crossref
Lars Radke, Grit Sandig, Annika Lubitz, Ulrike Schließer, Hans von Horsten, Veronique Blanchard, Karolin Keil, Volker Sandig, Christoph Giese, Michael Hummel, Stephan Hinderlich & Marcus Frohme. (2017) In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor. Bioengineering 4:4, pages 70.
Crossref
Crossref
Robert E. Sealy, Sherri L. Surman & Julia L. Hurwitz. (2017) CD4 + T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection. Vaccine 35:20, pages 2617-2621.
Crossref
Crossref
Kirsten Schneider-Ohrum, Corinne Cayatte, Angie Snell Bennett, Gaurav Manohar Rajani, Patrick McTamney, Krystal Nacel, Leigh Hostetler, Lily Cheng, Kuishu Ren, Terrence O'Day, Gregory A. Prince & Michael P. McCarthy. (2017) Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant. Journal of Virology 91:8.
Crossref
Crossref
G.M. Mortimer & R.F. Minchin. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
373
392
.
Manijeh Berenji. 2016. Physical and Biological Hazards of the Workplace. Physical and Biological Hazards of the Workplace
275
346
.
M. Oliveira-Santos, J. A. Santos, J. Soares, A. Dias & M. Quaresma. (2016) Influence of meteorological conditions on RSV infection in Portugal. International Journal of Biometeorology 60:12, pages 1807-1817.
Crossref
Crossref
Elisa C. Martinez, Ravendra Garg, Pratima Shrivastava, Susantha Gomis & Sylvia van Drunen Littel-van den Hurk. (2016) Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice. Antiviral Research 135, pages 108-119.
Crossref
Crossref
Myra N. Widjojoatmodjo, Lies Bogaert, Bob Meek, Roland Zahn, Jort Vellinga, Jerome Custers, Jan Serroyen, Katarina Radošević & Hanneke Schuitemaker. (2015) Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats. Vaccine 33:41, pages 5406-5414.
Crossref
Crossref
Geraldine TaylorMichelle ThomStefania CaponeAngiolo PierantoniEfrain GuzmanRebecca HerbertElisa ScarselliFederico NapolitanoAlessandro GiulianiAntonella FolgoriStefano CollocaRiccardo CorteseAlfredo NicosiaAlessandra Vitelli. (2015) Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections. Science Translational Medicine 7:300.
Crossref
Crossref
Jin Huk Choi, Stephen C. Schafer, Alexander N. Freiberg & Maria A. Croyle. (2015) Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine. Molecular Pharmaceutics 12:8, pages 2697-2711.
Crossref
Crossref
Kathryn Patton, Shahin Aslam, Cindy Shambaugh, Rui Lin, Darren Heeke, Chris Frantz, Fengrong Zuo, Mark T. Esser, Xavier Paliard & Stacie L. Lambert. (2015) Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques. Vaccine 33:36, pages 4472-4478.
Crossref
Crossref
Guillaume B. E. Stewart-Jones, Paul V. Thomas, Man Chen, Aliaksandr Druz, M. Gordon Joyce, Wing-Pui Kong, Mallika Sastry, Cinque Soto, Yongping Yang, Baoshan Zhang, Lei Chen, Gwo-Yu Chuang, Ivelin S. Georgiev, Jason S. McLellan, Sanjay Srivatsan, Tongqing Zhou, Ulrich Baxa, John R. Mascola, Barney S. Graham & Peter D. Kwong. (2015) A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus. PLOS ONE 10:6, pages e0128779.
Crossref
Crossref
Tie‐Gang Zhang, Ai‐Hua Li, Min Lyu, Meng Chen, Fang Huang & Jiang Wu. (2015) Detection of respiratory viral and bacterial pathogens causing pediatric community‐acquired pneumonia in Beijing using real‐time PCR. Chronic Diseases and Translational Medicine 1:2, pages 110-116.
Crossref
Crossref
Stacie L. Lambert, Shahin Aslam, Elizabeth Stillman, Mia MacPhail, Christine Nelson, Bodrey Ro, Rosemary Sweetwood, Yuk Man Lei, Jennifer C. Woo & Roderick S. Tang. (2015) A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective TH1-Type Humoral and Cellular Immunity In Rodent Models. PLOS ONE 10:3, pages e0119509.
Crossref
Crossref
Ryan Tuttle, Anja Weick, Wiebke Sabrina Schwarz, Xi Chen, Patrick Obermeier, Lea Seeber, Franziska Tief, Susann Muehlhans, Katharina Karsch, Christian Peiser, Susanne Duwe, Brunhilde Schweiger & Barbara Rath. (2015) Evaluation of novel second-generation RSV and influenza rapid tests at the point of care. Diagnostic Microbiology and Infectious Disease 81:3, pages 171-176.
Crossref
Crossref
Simon S. M. WongJanice W. L. YuKa Tak WongNelson LeeGrace C. Y. LuiPaul K. S. ChanAnil T. Ahuja. (2014) Initial Radiographic Features as Outcome Predictor of Adult Respiratory Syncytial Virus Respiratory Tract Infection. American Journal of Roentgenology 203:2, pages 280-286.
Crossref
Crossref
Kejian Yang & Steven M Varga. (2014) Mucosal vaccines against respiratory syncytial virus. Current Opinion in Virology 6, pages 78-84.
Crossref
Crossref
Bart G. Jones, Robert E. Sealy, Sherri L. Surman, Allen Portner, Charles J. Russell, Karen S. Slobod, Philip R. Dormitzer, John DeVincenzo & Julia L. Hurwitz. (2014) Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model. Vaccine 32:26, pages 3264-3273.
Crossref
Crossref
Shannon I. Phan, Zhenhai Chen, Pei Xu, Zhuo Li, Xiudan Gao, Stephanie L. Foster, Michael N. Teng, Ralph A. Tripp, Kaori Sakamoto & Biao He. (2014) A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5). Vaccine 32:25, pages 3050-3057.
Crossref
Crossref
Bo Liang, Shirin Munir, Emerito Amaro-Carambot, Sonja Surman, Natalie Mackow, Lijuan Yang, Ursula J. Buchholz, Peter L. Collins & Anne Schaap-Nutt. (2014) Chimeric Bovine/Human Parainfluenza Virus Type 3 Expressing Respiratory Syncytial Virus (RSV) F Glycoprotein: Effect of Insert Position on Expression, Replication, Immunogenicity, Stability, and Protection against RSV Infection. Journal of Virology 88:8, pages 4237-4250.
Crossref
Crossref
Vichtavat Auksornkitti, Nichaphat Kamprasert, Siwanat Thongkomplew, Kamol Suwannakarn, Apiradee Theamboonlers, Rujipat Samransamruajkij & Yong Poovorawan. (2013) Molecular characterization of human respiratory syncytial virus, 2010-2011: identification of genotype ON1 and a new subgroup B genotype in Thailand. Archives of Virology 159:3, pages 499-507.
Crossref
Crossref
Teresa R Johnson, David Rangel, Barney S Graham, Douglas E Brough & Jason G Gall. (2014) Genetic Vaccine for Respiratory Syncytial Virus Provides Protection Without Disease Potentiation. Molecular Therapy 22:1, pages 196-205.
Crossref
Crossref
L. M. Haynes. (2013) Progress and Challenges in RSV Prophylaxis and Vaccine Development. Journal of Infectious Diseases 208:suppl 3, pages S177-S183.
Crossref
Crossref
Jan C Varada, Belete Teferedegne, R Lynne Crim, Thembi Mdluli, Susette Audet, Keith Peden, Judy Beeler & Haruhiko Murata. (2013) A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment. Virology Journal 10:1.
Crossref
Crossref
Alan Rigter, Ivy Widjaja, Hanneke Versantvoort, Frank E. J. Coenjaerts, Maarten van Roosmalen, Kees Leenhouts, Peter J. M. Rottier, Bert Jan Haijema & Cornelis A. M. de Haan. (2013) A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles. PLoS ONE 8:8, pages e71072.
Crossref
Crossref
Christine A Shaw, Max Ciarlet, Brian W Cooper, Lamberto Dionigi, Paula Keith, Karen B O’Brien, Maryam Rafie-Kolpin & Philip R Dormitzer. (2013) The path to an RSV vaccine. Current Opinion in Virology 3:3, pages 332-342.
Crossref
Crossref
Chris Stockmann, Krow Ampofo, Adam L. Hersh, Scott T. Carleton, Kent Korgenski, Xiaoming Sheng, Andrew T. Pavia & Carrie L. Byington. (2013) Seasonality of Acute Otitis Media and the Role of Respiratory Viral Activity in Children. Pediatric Infectious Disease Journal 32:4, pages 314-319.
Crossref
Crossref
L.J. Anderson, P.R. Dormitzer, D.J. Nokes, R. Rappuoli, A. Roca & B.S. Graham. (2013) Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine 31, pages B209-B215.
Crossref
Crossref
Larry J. Anderson. (2013) Respiratory syncytial virus vaccine development. Seminars in Immunology 25:2, pages 160-171.
Crossref
Crossref
Peter Michael Moyle & Istvan Toth. (2013) Modern Subunit Vaccines: Development, Components, and Research Opportunities. ChemMedChem 8:3, pages 360-376.
Crossref
Crossref
Rajeev Rudraraju, Bart Jones, Robert Sealy, Sherri Surman & Julia Hurwitz. (2013) Respiratory Syncytial Virus: Current Progress in Vaccine Development. Viruses 5:2, pages 577-594.
Crossref
Crossref
Sumanta Mukherjee & Nicholas W. Lukacs. 2013. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
139
154
.
Rebecca J. Loomis & Philip R. Johnson. 2013. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
307
324
.
Randy Sacco, Jodi McGill, Mitchell Palmer, John Lippolis, Timothy Reinhardt & Brian Nonnecke. (2012) Neonatal Calf Infection with Respiratory Syncytial Virus: Drawing Parallels to the Disease in Human Infants. Viruses 4:12, pages 3731-3753.
Crossref
Crossref
Kimberly Dyer, Katia Garcia-Crespo, Stephanie Glineur, Joseph Domachowske & Helene Rosenberg. (2012) The Pneumonia Virus of Mice (PVM) Model of Acute Respiratory Infection. Viruses 4:12, pages 3494-3510.
Crossref
Crossref
Judy Trivits Verger & Emily Elizabeth Verger. (2012) Respiratory Syncytial Virus Bronchiolitis in Children. Critical Care Nursing Clinics of North America 24:4, pages 555-572.
Crossref
Crossref
Bart G. Jones, Robert E. Sealy, Rajeev Rudraraju, Vicki L. Traina-Dorge, Brad Finneyfrock, Anthony Cook, Toru Takimoto, Allen Portner & Julia L. Hurwitz. (2012) Sendai virus-based RSV vaccine protects African green monkeys from RSV infection. Vaccine 30:5, pages 959-968.
Crossref
Crossref